These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 27038356

  • 1. Case-only designs for studying the association of antidepressants and hip or femur fracture.
    de Groot MC, Candore G, Uddin MJ, Souverein PC, Ali MS, Belitser SV, Huerta C, Groenwold RH, Alvarez Y, Slattery J, Korevaar J, Hoes AW, Roes KC, de Boer A, Douglas IJ, Schlienger RG, Reynolds R, Klungel OH, Gardarsdottir H.
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():103-13. PubMed ID: 27038356
    [Abstract] [Full Text] [Related]

  • 2. Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.
    Souverein PC, Abbing-Karahagopian V, Martin E, Huerta C, de Abajo F, Leufkens HG, Candore G, Alvarez Y, Slattery J, Miret M, Requena G, Gil MJ, Groenwold RH, Reynolds R, Schlienger RG, Logie JW, de Groot MC, Klungel OH, van Staa TP, Egberts TC, De Bruin ML, Gardarsdottir H.
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():88-102. PubMed ID: 27038355
    [Abstract] [Full Text] [Related]

  • 3. Do case-only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepines.
    Requena G, Logie J, Martin E, Boudiaf N, González González R, Huerta C, Alvarez A, Webb D, Bate A, García Rodríguez LA, Reynolds R, Schlienger R, Gardarsdottir H, de Groot M, Klungel OH, de Abajo F, Douglas IJ.
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1(Suppl Suppl 1):79-87. PubMed ID: 26112821
    [Abstract] [Full Text] [Related]

  • 4. Instrumental variables analysis using multiple databases: an example of antidepressant use and risk of hip fracture.
    Uddin MJ, Groenwold RH, de Boer A, Gardarsdottir H, Martin E, Candore G, Belitser SV, Hoes AW, Roes KC, Klungel OH.
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():122-31. PubMed ID: 27038358
    [Abstract] [Full Text] [Related]

  • 5. Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture.
    Ali MS, Groenwold RH, Belitser SV, Souverein PC, Martín E, Gatto NM, Huerta C, Gardarsdottir H, Roes KC, Hoes AW, de Boer A, Klungel OH.
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():114-21. PubMed ID: 27038357
    [Abstract] [Full Text] [Related]

  • 6. Impact of pre-exposure time bias in self-controlled case series when the event conditions the exposure: Hip/femur fracture and use of benzodiazepines as a case study.
    Requena G, Douglas IJ, Huerta C, de Abajo F.
    Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):388-395. PubMed ID: 31923351
    [Abstract] [Full Text] [Related]

  • 7. Association Between Antidepressant Drug Use and Hip Fracture in Older People Before and After Treatment Initiation.
    Brännström J, Lövheim H, Gustafson Y, Nordström P.
    JAMA Psychiatry; 2019 Feb 01; 76(2):172-179. PubMed ID: 30601883
    [Abstract] [Full Text] [Related]

  • 8. Association of fracture risk with benzodiazepine among adults in South Korea.
    Hwang JS, Oh SH, Oh KS, Lee KU, Woo JM, Lee BC, Park E, Kwak SJ, Kwon JW.
    Int J Clin Pharmacol Ther; 2015 Feb 01; 53(2):163-71. PubMed ID: 25492849
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Psychoactive medicine use and the risk of hip fracture in older people: a case-crossover study.
    Leach MJ, Pratt NL, Roughead EE.
    Pharmacoepidemiol Drug Saf; 2015 Jun 01; 24(6):576-82. PubMed ID: 25879164
    [Abstract] [Full Text] [Related]

  • 11. When should case-only designs be used for safety monitoring of medical products?
    Maclure M, Fireman B, Nelson JC, Hua W, Shoaibi A, Paredes A, Madigan D.
    Pharmacoepidemiol Drug Saf; 2012 Jan 01; 21 Suppl 1():50-61. PubMed ID: 22262593
    [Abstract] [Full Text] [Related]

  • 12. Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project.
    Requena G, Huerta C, Gardarsdottir H, Logie J, González-González R, Abbing-Karahagopian V, Miret M, Schneider C, Souverein PC, Webb D, Afonso A, Boudiaf N, Martin E, Oliva B, Alvarez A, De Groot MC, Bate A, Johansson S, Schlienger R, Reynolds R, Klungel OH, de Abajo FJ.
    Pharmacoepidemiol Drug Saf; 2016 Mar 01; 25 Suppl 1():66-78. PubMed ID: 26100105
    [Abstract] [Full Text] [Related]

  • 13. All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture.
    de Bruin IJA, Klop C, Wyers CE, Overbeek JA, Geusens PPMM, van den Bergh JPW, Driessen JHM, de Vries F.
    Osteoporos Int; 2019 Mar 01; 30(3):573-581. PubMed ID: 30737577
    [Abstract] [Full Text] [Related]

  • 14. A data visualisation method for assessing exposure misclassification in case-crossover studies: the example of tricyclic antidepressants and the risk of hip fracture in older people.
    Leach MJ, Roughead EE, Pratt NL.
    BMC Med Res Methodol; 2021 Feb 27; 21(1):43. PubMed ID: 33639849
    [Abstract] [Full Text] [Related]

  • 15. Risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy among elderly males: a self-controlled case series study.
    Lai CL, Kuo RN, Chen HM, Chen MF, Chan KA, Lai MS.
    Br J Clin Pharmacol; 2015 Nov 27; 80(5):1208-18. PubMed ID: 25924025
    [Abstract] [Full Text] [Related]

  • 16. Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study.
    Arbouw ME, Movig KL, van Staa TP, Egberts AC, Souverein PC, de Vries F.
    Osteoporos Int; 2011 Jul 27; 22(7):2197-204. PubMed ID: 20967420
    [Abstract] [Full Text] [Related]

  • 17. Risk of hip/femur fracture after stroke: a population-based case-control study.
    Pouwels S, Lalmohamed A, Leufkens B, de Boer A, Cooper C, van Staa T, de Vries F.
    Stroke; 2009 Oct 27; 40(10):3281-5. PubMed ID: 19661475
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.
    Taipale H, Rysä J, Hukkanen J, Koponen M, Tanskanen A, Tiihonen J, Kröger H, Hartikainen S, Tolppanen AM.
    Osteoporos Int; 2019 Jul 27; 30(7):1481-1489. PubMed ID: 30993395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.